Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01157234Phase 4Completed
Phase 4, randomised trial of nebivolol in hypertension (HTN) (2 arms), sponsored by University of Florida. Primary endpoint: Plasma Nitric Oxide Level Change at 12 months. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01157234.